Javascript must be enabled to continue!
Introduction to Neurooncology
View through CrossRef
Abstract
CNS tumors may be primary or secondary. Primary CNS tumors develop initially within the brain, spinal cord, optic nerves, cranial or spinal nerve roots, leptomeninges, and dura. Pituitary tumors are primary intracranial tumors and are sometimes classified as primary CNS tumors. Secondary tumors originate from primary neoplasms arising in organs, structures, and tissues outside the CNS and reach the CNS either by direct extension when the primary tumor is located in a contiguous structure such as the base of the skull or by metastasis, indicated by absence of continuity between the CNS tumor deposit and its primary source outside the CNS. Primary CNS tumors are generally classified according to their cellular origin (glioma, astrocytoma), their tissue of origin (meningioma, nerve sheath tumors), or their organ of origin (pinealoma). The craniopharyngioma is an exception to this scheme. Distinctive Characteristics Of CNS Tumors Although similar to systemic neoplasms in some respects, tumors involving the central nervous system have the following distinctive characteristics. • Primary central nervous system tumors rarely metastasize outside the CNS. Malignancy is indicated by rapid growth, invasion of adjacent structures, and spread to other parts of the central nervous system along anatomic pathways such as the ventricular system or subarachnoid space. Even apparently benign tumors may cause considerable morbidity or death because they involve major blood vessels or other vital structures and cannot be safely excised. Such tumors are categorized more appropriately as slowly growing rather than benign. They are sometimes described as “malignant by position.”
Oxford University PressNew York, NY
Title: Introduction to Neurooncology
Description:
Abstract
CNS tumors may be primary or secondary.
Primary CNS tumors develop initially within the brain, spinal cord, optic nerves, cranial or spinal nerve roots, leptomeninges, and dura.
Pituitary tumors are primary intracranial tumors and are sometimes classified as primary CNS tumors.
Secondary tumors originate from primary neoplasms arising in organs, structures, and tissues outside the CNS and reach the CNS either by direct extension when the primary tumor is located in a contiguous structure such as the base of the skull or by metastasis, indicated by absence of continuity between the CNS tumor deposit and its primary source outside the CNS.
Primary CNS tumors are generally classified according to their cellular origin (glioma, astrocytoma), their tissue of origin (meningioma, nerve sheath tumors), or their organ of origin (pinealoma).
The craniopharyngioma is an exception to this scheme.
Distinctive Characteristics Of CNS Tumors Although similar to systemic neoplasms in some respects, tumors involving the central nervous system have the following distinctive characteristics.
• Primary central nervous system tumors rarely metastasize outside the CNS.
Malignancy is indicated by rapid growth, invasion of adjacent structures, and spread to other parts of the central nervous system along anatomic pathways such as the ventricular system or subarachnoid space.
Even apparently benign tumors may cause considerable morbidity or death because they involve major blood vessels or other vital structures and cannot be safely excised.
Such tumors are categorized more appropriately as slowly growing rather than benign.
They are sometimes described as “malignant by position.
”.
Related Results
P22.03.A ASSESSING PALLIATIVE CARE APPROACHES IN NEUROONCOLOGY: INSIGHTS FROM GERMANY
P22.03.A ASSESSING PALLIATIVE CARE APPROACHES IN NEUROONCOLOGY: INSIGHTS FROM GERMANY
Abstract
BACKGROUND
This study aims to assess the palliative care practices across neurooncology centres in Germany, focusing on...
P18.19.A EVOLVING STANDARDS: THE INTEGRATION OF NEW THERAPIES INTO NEUROONCOLOGY GUIDELINES
P18.19.A EVOLVING STANDARDS: THE INTEGRATION OF NEW THERAPIES INTO NEUROONCOLOGY GUIDELINES
Abstract
BACKGROUND
In the swiftly progressing domain of neurooncology, continuously updated clinical guidelines are essential t...
Supportive therapy in neurooncology patients
Supportive therapy in neurooncology patients
Supportive therapy of neurooncology patients is an important part of their overall medical treatment. Many aspects of supportive therapy are common to all paediatric oncology patie...
Ultrasound elastography in neurooncology: Basic principles, applications, and illustrative cases
Ultrasound elastography in neurooncology: Basic principles, applications, and illustrative cases
Abstract
Intraoperative ultrasound as an adjunct for brain and spinal cord tumors has seen an uptick in interest over the last few decades owing to real-time imaging, eas...
Molecular Warriors: Targeted Therapy's Role in Shaping NeuroOncology
Molecular Warriors: Targeted Therapy's Role in Shaping NeuroOncology
Molecular Warriors: Targeted Therapy's Role in Shaping NeuroOncology...
SCSS-02. INVOLVEMENT OF SUPPORTIVE CARE TEAM AND SOCIAL WORK IN NEUROONCOLOGY IN A TERTIARY CARE HOSPITAL
SCSS-02. INVOLVEMENT OF SUPPORTIVE CARE TEAM AND SOCIAL WORK IN NEUROONCOLOGY IN A TERTIARY CARE HOSPITAL
Abstract
BACKGROUND/OBJECTIVES
Supportive Care and Social Work services are underutilized in Neurooncology. ASCO Quality Oncolog...
First person – Tanja Müller
First person – Tanja Müller
ABSTRACT
First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping researchers promote the...
Artificial intelligence- image learning and its applications in neurooncology: a review
Artificial intelligence- image learning and its applications in neurooncology: a review
Image learning involves using artificial intelligence (AI) to analyse radiological images. Various machine and deeplearning- based techniques have been employed to process images a...

